Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands

Pharmazie. 2001 Apr;56(4):287-9.

Abstract

A novel series of potential antipsychotic agents were prepared by combination of condensed heterocycles containing bridgehead nitrogen with (2-methoxyphenyl)piperazine using phenoxyalkyl spacer of variable length. The affinity of the compounds was determined at rat cloned D3 and rat D2, 5-HT1A receptors by an vitro receptor binding assay. The D3 selectivity of the compounds was calculated from the Ki values.

MeSH terms

  • Animals
  • Binding, Competitive / drug effects
  • Dopamine Agents / chemical synthesis*
  • Dopamine Agents / pharmacology*
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Kinetics
  • Ligands
  • Neostriatum / drug effects
  • Neostriatum / metabolism
  • Piperazines / chemical synthesis*
  • Piperazines / pharmacology*
  • Rats
  • Receptors, Dopamine D2 / drug effects*
  • Receptors, Dopamine D3
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin, 5-HT1
  • Serotonin Agents / chemical synthesis
  • Serotonin Agents / pharmacology

Substances

  • Dopamine Agents
  • Drd3 protein, rat
  • Ligands
  • Piperazines
  • Receptors, Dopamine D2
  • Receptors, Dopamine D3
  • Receptors, Serotonin
  • Receptors, Serotonin, 5-HT1
  • Serotonin Agents